Lisong Teng

533 total citations
14 papers, 430 citations indexed

About

Lisong Teng is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Lisong Teng has authored 14 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 6 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Lisong Teng's work include Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (4 papers) and RNA modifications and cancer (3 papers). Lisong Teng is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (4 papers) and RNA modifications and cancer (3 papers). Lisong Teng collaborates with scholars based in China, Canada and United States. Lisong Teng's co-authors include Kuifeng He, Jiang Cao, Haohao Wang, Zhonghai Guan, Mengjie Li, Juan Jin, Wei Zhuo, Dongyang Guo, Qiang Sun and Meng Sun and has published in prestigious journals such as Gastroenterology, Oncotarget and Frontiers in Oncology.

In The Last Decade

Lisong Teng

13 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lisong Teng China	9	345	331	55	43	42	14	430
Kunhou Yao China	11	357 1.0×	350 1.1×	53 1.0×	31 0.7×	47 1.1×	24	446
Amir Sadra Zangouei Iran	12	306 0.9×	249 0.8×	48 0.9×	35 0.8×	28 0.7×	28	397
Jinxue Tong China	9	270 0.8×	138 0.4×	90 1.6×	30 0.7×	30 0.7×	19	347
Xiaojiao Ban China	6	329 1.0×	209 0.6×	70 1.3×	31 0.7×	41 1.0×	8	412
María José Lorenzo-Patiño Spain	6	225 0.7×	209 0.6×	76 1.4×	31 0.7×	23 0.5×	6	312
Min Cheng China	10	218 0.6×	209 0.6×	47 0.9×	54 1.3×	21 0.5×	19	326
Xin-Tai Zhao China	8	328 1.0×	264 0.8×	76 1.4×	25 0.6×	21 0.5×	11	415
Tianyao Lei China	10	407 1.2×	339 1.0×	59 1.1×	77 1.8×	16 0.4×	12	473
Zhonghai Guan China	8	280 0.8×	189 0.6×	78 1.4×	41 1.0×	29 0.7×	18	370

Countries citing papers authored by Lisong Teng

Since Specialization

Citations

This map shows the geographic impact of Lisong Teng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisong Teng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisong Teng more than expected).

Fields of papers citing papers by Lisong Teng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisong Teng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisong Teng. The network helps show where Lisong Teng may publish in the future.

Co-authorship network of co-authors of Lisong Teng

This figure shows the co-authorship network connecting the top 25 collaborators of Lisong Teng. A scholar is included among the top collaborators of Lisong Teng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisong Teng. Lisong Teng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Su, Xingyun, et al.. (2025). Independent Clonal Origin in Early‐Stage Bilateral Papillary Thyroid Cancer: Evidence From Nuclear and Mitochondrial Genome Analysis. Molecular Carcinogenesis. 64(11). 1851–1859.

Yu, Shanshan, Ming Chen, Xiaohua Zhu, et al.. (2024). The combination of exon sequencing and metabolomics to establish a molecular typing system for gastric cancer. Heliyon. 10(15). e34317–e34317. 2 indexed citations

Han, Chun, et al.. (2022). miR-183-5p promotes proliferation, invasion, and glycolysis of thyroid carcinoma cells by targeting FOXO1. Molecular and Cellular Biochemistry. 477(4). 1195–1206. 10 indexed citations

Zhang, Yu, Jinwang Ding, You Peng, et al.. (2022). Identification of Long Noncoding RNAs Associated With the Clinicopathological Features of Papillary Thyroid Carcinoma Complicated With Hashimoto’s Thyroiditis. Frontiers in Oncology. 12. 766016–766016. 5 indexed citations

Ding, Yongfeng, et al.. (2021). Identification of Serum Circulating MicroRNAs as Novel Diagnostic Biomarkers of Gastric Cancer. Frontiers in Genetics. 11. 591515–591515. 23 indexed citations

Zhang, Jun, et al.. (2018). Iodine‑125 interstitial brachytherapy reduces tumor growth via Warburg effect inhibition in non‑small cell lung cancer A549 xenografts. Oncology Letters. 16(5). 5969–5977. 9 indexed citations

Zhuo, Wei, Yiman Liu, Shuang Li, et al.. (2018). Long Noncoding RNA GMAN, Up-regulated in Gastric Cancer Tissues, Is Associated With Metastasis in Patients and Promotes Translation of Ephrin A1 by Competitively Binding GMAN-AS. Gastroenterology. 156(3). 676–691.e11. 206 indexed citations

Wang, Haohao, et al.. (2017). LncRNA UCA1 in anti-cancer drug resistance. Oncotarget. 8(38). 64638–64650. 129 indexed citations

Mao, Chenyu, Hao Liu, Ping Chen, et al.. (2015). Cell-specific expression of artificial microRNAs targeting essential genes exhibit potent antitumor effect on hepatocellular carcinoma cells. Oncotarget. 6(8). 5707–5719. 7 indexed citations

10.

Teng, Lisong, et al.. (2012). Clinicopathological and Prognostic Implications of Arginase Expression in Hepatocellular Carcinoma. Clinical Laboratory. 59(01+02/2013). 37–43. 11 indexed citations

11.

Jin, Ketao, Huanrong Lan, Bojian Xie, et al.. (2012). Antitumor effects of FP3 in combination with capecitabine on PDTT xenograft models of primary colon carcinoma and related lymphatic and hepatic metastases. Cancer Biology & Therapy. 13(9). 737–744. 8 indexed citations

12.

Jin, Ketao, Kuifeng He, Fei Teng, et al.. (2011). Heterogeneity in Primary Tumors and Corresponding Metastases: Could it Provide Us with any Hints to Personalize Cancer Therapy?. Personalized Medicine. 8(2). 175–182. 8 indexed citations

13.

Jin, Ketao, Kuifeng He, Guangliang Li, & Lisong Teng. (2010). Personalized Cancer Therapy Using a Patient-Derived Tumor Tissue Xenograft Model: A tRanslational Field Worthy of Exploring Further?. Personalized Medicine. 7(5). 597–606. 8 indexed citations

14.

Teng, Lisong, et al.. (2002). Stable expression of antisense hTR inhibits in vitro pancreatic cancer cell growth.. PubMed. 115(8). 1196–200. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact